STOCK TITAN

STERIS (STE) director Pierre Boulud receives 367 Career Restricted Stock Units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

STERIS plc director Pierre Boulud received a grant of 367 Career Restricted Stock Units. These derivative awards were acquired at a price of 0.0000 per unit and are linked to 367 underlying STERIS ordinary shares.

Each Career Restricted Stock Unit represents the right to receive one ordinary share six months after the end of his Board service. The units are fully vested immediately but will only be settled in shares six months after his service on the Board ceases. Following this grant, he holds 367 Career Restricted Stock Units directly.

Positive

  • None.

Negative

  • None.
Insider Boulud Pierre
Role null
Type Security Shares Price Value
Grant/Award Career Restricted Stock Units 367 $0.00 --
Holdings After Transaction: Career Restricted Stock Units — 367 shares (Direct, null)
Footnotes (1)
  1. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Career Restricted Stock Units granted 367 units Grant to director Pierre Boulud on 2026-06-02
Underlying ordinary shares 367 shares Each unit represents one STERIS ordinary share
Grant price per unit 0.0000 Reported transaction price per Career Restricted Stock Unit
Career RSUs held after transaction 367 units Total Career Restricted Stock Units directly owned following grant
Career Restricted Stock Units financial
"Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service."
fully vested financial
"These Career Restricted Stock Units are fully vested immediately."
settled in STERIS ordinary shares financial
"They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Boulud Pierre

(Last)(First)(Middle)
C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)
DUBLIN 2D02 R296

(City)(State)(Zip)

IRELAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Career Restricted Stock Units(1)06/02/2026A367 (2) (2)Ordinary Shares367$0367D
Explanation of Responses:
1. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
2. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did STERIS (STE) director Pierre Boulud report?

Pierre Boulud reported receiving 367 Career Restricted Stock Units of STERIS. These are derivative awards linked to 367 underlying ordinary shares, acquired at a price of 0.0000 per unit and held directly following the transaction.

How many STERIS (STE) Career Restricted Stock Units did the director receive?

He received 367 Career Restricted Stock Units. Each unit is tied to one STERIS ordinary share, so the grant relates to 367 underlying shares, all recorded as directly owned after this Form 4 transaction.

When will Pierre Boulud’s STERIS (STE) Career RSUs be settled into shares?

The Career Restricted Stock Units will be settled in STERIS ordinary shares six months after his Board service ends. Settlement timing is therefore linked specifically to the cessation of his service as a director.

Are the STERIS (STE) Career Restricted Stock Units granted to the director vested?

Yes, the Career Restricted Stock Units are fully vested immediately. Although vested now, they will only convert into STERIS ordinary shares six months after the director’s Board service ceases, according to the filing footnotes.

Does each STERIS (STE) Career Restricted Stock Unit equal one ordinary share?

Yes. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share. The grant of 367 units therefore corresponds to 367 ordinary shares when the units are ultimately settled.